Stockscreener 앱 받기
16.67
1.15%
0.19
시간 외 거래:
16.68
0.010
+0.06%
전일 마감가:
$16.48
열려 있는:
$16.53
하루 거래량:
7.53M
Relative Volume:
1.26
시가총액:
$8.28B
수익:
$4.45B
순이익/손실:
$205.00M
주가수익비율:
41.68
EPS:
0.4
순현금흐름:
$372.00M
1주 성능:
+20.88%
1개월 성능:
+13.02%
6개월 성능:
+44.70%
1년 성능:
+28.33%
1일 변동 폭
$16.15
$16.67
1주일 범위
$13.75
$16.70
52주 변동 폭
$8.02
$16.70
엘란코 Stock (ELAN) Company Profile
명칭
Elanco Animal Health Inc
전화
877-352-6261
주소
2500 INNOVATION WAY, GREENFIELD
ELAN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
16.67 | 6.93B | 4.45B | 205.00M | 372.00M | 0.40 |
|
ZTS
Zoetis Inc
|
147.35 | 64.93B | 9.39B | 2.61B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.44 | 45.07B | 29.98B | 958.27M | 5.31B | 0.2964 |
|
HLN
Haleon Plc Adr
|
9.54 | 41.53B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.37 | 18.37B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
301.50 | 13.68B | 2.99B | 1.21B | 1.13B | 25.06 |
엘란코 Stock (ELAN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-17 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2025-06-26 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2024-12-09 | 개시 | UBS | Buy |
| 2024-12-02 | 개시 | Leerink Partners | Market Perform |
| 2024-09-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-05 | 업그레이드 | Stifel | Hold → Buy |
| 2023-12-19 | 개시 | Jefferies | Buy |
| 2023-12-15 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-07 | 개시 | Exane BNP Paribas | Outperform |
| 2023-04-20 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2022-08-18 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-16 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-07-21 | 다운그레이드 | Goldman | Buy → Sell |
| 2022-07-12 | 개시 | Piper Sandler | Neutral |
| 2021-11-18 | 개시 | Morgan Stanley | Overweight |
| 2021-10-28 | 다운그레이드 | Stifel | Buy → Hold |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-06-15 | 업그레이드 | Cleveland Research | Underperform → Neutral |
| 2021-05-11 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2021-05-11 | 업그레이드 | Gabelli & Co | Hold → Buy |
| 2021-04-15 | 개시 | Stifel | Buy |
| 2021-03-22 | 다운그레이드 | Gabelli & Co | Buy → Hold |
| 2021-02-26 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2020-12-09 | 다운그레이드 | Argus | Buy → Hold |
| 2020-11-09 | 다운그레이드 | Barclays | Overweight → Underweight |
| 2020-08-20 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-08-13 | 재개 | Credit Suisse | Neutral |
| 2020-08-04 | 재개 | Goldman | Buy |
| 2020-07-27 | 다운그레이드 | Cleveland Research | Neutral → Underperform |
| 2020-04-02 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-10 | 개시 | Raymond James | Mkt Perform |
| 2019-12-19 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-11-07 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-23 | 개시 | Barclays | Overweight |
| 2019-08-26 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-08-15 | 업그레이드 | UBS | Sell → Neutral |
| 2019-05-23 | 개시 | Guggenheim | Neutral |
| 2019-03-18 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-03-13 | 재개 | Morgan Stanley | Equal-Weight |
| 2019-02-12 | 개시 | William Blair | Mkt Perform |
| 2019-01-23 | 개시 | UBS | Sell |
| 2019-01-15 | 개시 | Argus | Buy |
| 2018-10-15 | 개시 | Morgan Stanley | Equal-Weight |
모두보기
엘란코 주식(ELAN)의 최신 뉴스
Elanco Puppy Virus Treatment Expanded With USDA Approval - InkFreeNews.com
UBS Raises PT to $19 for Elanco Animal Health Amid Bullish Outlook - AInvest
Elanco (ELAN) Jumps 19.7% to Record High on Earnings Boost - MSN
Elanco Animal Health 2025 Q2 Earnings Strong Performance as Net Income Surges 122% - AInvest
Elanco Raises 2025 Innovation Revenue Outlook to $720M-$800M, Signals Margin Expansion Through New Launches. - AInvest
10 Hot Stocks Making Winning Look Easy - Insider Monkey
Elanco (ELAN) Q2 Revenue Jumps 5% - AOL.com
Elanco's Q2 2025 Earnings Call: Unraveling Key Contradictions in FX Impact, Innovation Growth, and Margin Dynamics - AInvest
Elanco Animal Health Q2 2025: Innovation-Driven Growth and Accelerated Deleveraging Justify a Buy Rating - AInvest
Elanco Animal Health shares fall 1.55% after-hours despite beating Q2 revenue estimates and raising FY guidance. - AInvest
Elanco's Q2 Revenue Exceeds Expectations, Raises Full-Year Guidance - AInvest
Elanco bolsters parvovirus treatment with new approval - Inside INdiana Business
Elanco (NYSE:ELAN) Delivers Impressive Q2, Stock Jumps 15.4% - Yahoo Finance
Elanco Animal Health Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Earnings call transcript: Elanco Animal Health beats Q2 2025 expectations By Investing.com - Investing.com Canada
Why Is Elanco Animal Health Stock Soaring Thursday?Elanco Animal Health (NYSE:ELAN) - Benzinga
Elanco Animal Health stock hits 52-week high at $15.79 By Investing.com - Investing.com Canada
Elanco Animal Health (ELAN) Reports Q2 Earnings: What Key Metrics Have to Say - Yahoo Finance
Elanco Animal Health Inc SEC 10-Q Report - TradingView
Elanco stock spikes after Q2 beat, guidance raise (ELAN:NYSE) - Seeking Alpha
Elanco Animal Health Incorporated (ELAN) Q2 Earnings and Revenues Beat Estimates - Yahoo Finance
Elanco (ELAN) Q2 Revenue Jumps 5% - The Motley Fool
Elanco Animal Health earnings beat by $0.06, revenue topped estimates - Investing.com Canada
Elanco Q2 2025 slides: 8% organic growth drives raised guidance despite headwinds - Investing.com Canada
Elanco Animal Health Reports Second Quarter 2025 Results - TradingView
Elanco raises full-year guidance on strength of newest products - Indianapolis Business Journal
Curious about Elanco Animal Health (ELAN) Q2 Performance? Explore Wall Street Estimates for Key Metrics - Yahoo Finance
What To Expect From Elanco’s (ELAN) Q2 Earnings - Yahoo Finance
What catalysts could drive Elanco Animal Health Incorporated stock higher in 2025Build wealth steadily with proven investment techniques - Jammu Links News
How does Elanco Animal Health Incorporated generate profit in a changing economyBuild a diversified portfolio for stability - Jammu Links News
How many analysts rate Elanco Animal Health Incorporated as a “Buy”Identify breakout stocks before they peak - Jammu Links News
How volatile is Elanco Animal Health Incorporated stock compared to the marketAchieve breakthrough financial results - Jammu Links News
Will Elanco Animal Health Incorporated rebound enough to break evenSwing Trading Plan With Smart Signals in Review - metal.it
Why is Elanco Animal Health Incorporated stock attracting strong analyst attentionFree Stock Chart Pattern Guide - Jammu Links News
What institutional investors are buying Elanco Animal Health Incorporated stockMaximize your portfolio’s growth potential - Jammu Links News
What are Elanco Animal Health Incorporated company’s key revenue driversGet timely market insights for better trades - Jammu Links News
Animal Sedatives Market Is Going to Boom | Major Giants Zoetis, Elanco, Merck Animal Health, Ceva Santé Animale - openPR.com
Unexpected Trends Reshaping the Veterinary Oncology U.S. - openPR.com
Sector Rotation Brings Elanco Animal Health Incorporated Into FocusMulti-Bagger Potential Stock Forecast Tools Released - beatles.ru
Animal Growth Promoter Market Size and Share Forecast Outlook - openPR.com
Fish Vaccine Market Generated Opportunities, Future Scope - openPR.com
Elanco Animal Health Incorporated (NYSE:ELAN) Shares Bought by Victory Capital Management Inc. - MarketBeat
Elanco Animal Health Incorporated (NYSE:ELAN) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Allianz Asset Management GmbH Sells 317,192 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
European Commission approves Zenrelia - DVM360
Wyckoff Accumulation Phase Possible in Elanco Animal Health IncorporatedEntry Points For Growing Stocks Identified by Models - metal.it
Dogs Vaccines Market to Witness Comprehensive Growth by 2032 | - openPR.com
What are the latest earnings results for Elanco Animal Health IncorporatedLightning-fast capital gains - jammulinksnews.com
Does Elanco Animal Health Incorporated stock perform well during market downturnsBreakthrough profit margins - jammulinksnews.com
Elanco Animal Health Incorporated Company’s Quarterly Earnings Growth: What the Numbers SayMinimized Risk Trading Plan - metal.it
542,791 Shares in Elanco Animal Health Incorporated (NYSE:ELAN) Acquired by Universal Beteiligungs und Servicegesellschaft mbH - MarketBeat
엘란코 (ELAN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.30%
0.47%
자본화:
|
볼륨(24시간):